The latest call
FetchingCardiol Therapeutics Inc. reported on November 12, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
CRDL · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$1.01-3.8%Nov 13 close
Reported results on November 12, 2026; they are not in these figures yet.
Figures through December 31, 2025, from the 40-F filed March 31, 2026
The quarter ending December 31, 2024, against the same quarter a year earlier.
| Measure | 3 months toDec 31, 2024 | 3 months toJun 30, 2023 | Change |
|---|---|---|---|
| Free Cash Flow | -$3.9M | -$3.8M | -4.50% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
The quote and the company description come from the 6-K Cardiol Therapeutics Inc. filed on August 12, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Cardiol Therapeutics Inc. reported on November 12, 2026. We are fetching the call transcript; its summary follows once the transcript is in.